deltatrials
Completed PHASE2 INTERVENTIONAL 2-arm NCT03200860

Effects of Empagliflozin on Clinical Outcomes in Patients With Acute Decompensated Heart Failure (EMPA-RESPONSE)

Randomized, Double Blind, Placebo Controlled, Multicenter Pilot Study on the Effects of Empagliflozin on Clinical Outcomes in Patients With Acute Decompensated Heart Failure (EMPA-RESPONSE-AHF)

Sponsor: University Medical Center Groningen

Conditions Heart Failure Acute Heart Failure; With Decompensation Heart Failure，Congestive
Interventions Empagliflozin 10 MG Placebo Oral Tablet
Updated 14 times since 2017 Last updated: Apr 16, 2024 Started: Dec 18, 2017 Primary completion: Sep 18, 2019 Completion: Sep 18, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Heart Failure Acute and Heart Failure; With Decompensation, this trial is completed. The trial is conducted by University Medical Center Groningen and has accumulated 14 data snapshots since 2017. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

~Jul 2017 – ~Jan 2018 · 6 months · monthly snapshot~Jan 2018 – ~Jun 2018 · 5 months · monthly snapshot~Jun 2018 – ~Feb 2019 · 8 months · monthly snapshot~Feb 2019 – ~Aug 2019 · 6 months · monthly snapshot~Aug 2019 – ~Oct 2019 · 2 months · monthly snapshot~Oct 2019 – ~Mar 2020 · 5 months · monthly snapshot~Mar 2020 – ~Nov 2020 · 8 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshot~Dec 2021 – ~May 2024 · 29 months · monthly snapshot~May 2024 – ~Jul 2024 · 2 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

14 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  4. May 2024 — Jul 2024 [monthly]

    Completed PHASE2

  5. Dec 2021 — May 2024 [monthly]

    Completed PHASE2

▶ Show 9 earlier versions

  1. Jan 2021 — Dec 2021 [monthly]

    Completed PHASE2

  2. Nov 2020 — Jan 2021 [monthly]

    Completed PHASE2

  3. Mar 2020 — Nov 2020 [monthly]

    Completed PHASE2

  4. Oct 2019 — Mar 2020 [monthly]

    Completed PHASE2

    Status: Active Not Recruiting → Completed

  5. Aug 2019 — Oct 2019 [monthly]

    Active Not Recruiting PHASE2

    Status: Recruiting → Active Not Recruiting

  6. Feb 2019 — Aug 2019 [monthly]

    Recruiting PHASE2

  7. Jun 2018 — Feb 2019 [monthly]

    Recruiting PHASE2

  8. Jan 2018 — Jun 2018 [monthly]

    Recruiting PHASE2

    Status: Not Yet Recruiting → Recruiting

  9. Jul 2017 — Jan 2018 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University Medical Center Groningen
Data source: University Medical Center Groningen

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations